Navigating the landscape of terminal care and access to medications like Pentobarbital in New South Wales, Australia, requires a careful understanding of the intricate legal structure. Currently, this powerful sedative does not have a recognized place on the Pharmaceutical Benefits Scheme (this program) and is therefore not commonly prescribed by m